Interne link ProQR Announces First Quarter 2026 Operating and Financial Results mei 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform mei 11, 2026 om 12:00 PM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 mei 04, 2026 om 12:00 PM UTC
Interne link ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors april 30, 2026 om 12:00 PM UTC
Interne link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event april 08, 2026 om 08:00 PM UTC
Interne link ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board april 08, 2026 om 12:00 PM UTC
Interne link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 maart 25, 2026 om 12:00 PM UTC
Interne link ProQR Announces Year End 2025 Operating and Financial Results maart 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference maart 03, 2026 om 09:30 PM UTC
Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook januari 08, 2026 om 01:00 PM UTC
Interne link ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration december 11, 2024 om 12:00 PM UTC
Interne link ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist december 10, 2024 om 01:00 PM UTC
Interne link ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 december 05, 2024 om 01:00 PM UTC
Interne link ProQR Announces Third Quarter 2024 Operating and Financial Results november 07, 2024 om 12:00 PM UTC
Interne link ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement oktober 25, 2024 om 08:45 PM UTC
Interne link ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement oktober 23, 2024 om 02:15 AM UTC
Interne link ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares oktober 22, 2024 om 08:01 PM UTC
Interne link ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society oktober 07, 2024 om 12:00 PM UTC
Interne link ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference september 10, 2024 om 08:30 PM UTC
Interne link ProQR Announces Second Quarter 2024 Operating and Financial Results augustus 08, 2024 om 11:00 AM UTC
Interne link ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit juni 18, 2024 om 12:00 PM UTC
Interne link ProQR Announces First Quarter 2024 Operating and Financial Results mei 09, 2024 om 11:00 AM UTC
Interne link ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases mei 08, 2024 om 12:00 PM UTC
Interne link ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 april 23, 2024 om 11:00 AM UTC